2-tert-Butyl-9,10-di(naphth-2-yl)anthracene

Catalog No. :
ACMBEW942
CAS No. :
274905-73-6
Molecular Formula :
C38H30
Molecular Weight :
486.66

IUPAC Name:2-(tert-butyl)-9,10-di(naphthalen-2-yl)anthracene

2-tert-Butyl-9,10-di(naphth-2-yl)anthracene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$110.00Login to see priceIn stockInquiry
5g97%$395.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-tert-Butyl-9,10-di(naphth-2-yl)anthracene
IUPAC Name2-(tert-butyl)-9,10-di(naphthalen-2-yl)anthracene
MDL No.MFCD07644560
Molecular FormulaC38H30
Molecular Weight486.66
SMILESCC(C)(C)C1=CC2=C(C=C1)C(C1=CC3=C(C=CC=C3)C=C1)=C1C=CC=CC1=C2C1=CC2=C(C=CC=C2)C=C1
InChI KeyOBAJPWYDYFEBTF-UHFFFAOYSA-N
Synonym274905-73-6 | 2-tert-Butyl-9,10-di(naphth-2-yl)anthracene | TBADN | 2-tert-butyl-9,10-dinaphthalen-2-ylanthracene | 3-TERT-BUTYL-9,10-DI(NAPHTH-2-YL)ANTHRACENE | Anthracene, 2-(1,1-dimethylethyl)-9,10-di-2-naphthalenyl- | 2-tert-butyl-9,10-di(naphthalen-2-yl)anthrace
CAS No.274905-73-6
PubChem CID21896096

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H413
Precautionary Statement(s)
P264-P270-P273-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACMBEW942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACUEAM185 route compound structure diagram
    ACUEAM18532316-92-0 In Stock
  6. Then
  7. ACMBEW942 route product structure diagram
    ACMBEW942274905-73-6 In Stock
Inquiry

2. ACMBEW942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMBEW942 route product structure diagram
    ACMBEW942274905-73-6 In Stock
Inquiry

Comments (0)